Tenormin and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Tenormin (atenolol), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Zantac, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Tenormin. It is created by eHealthMe based on reports of 20,083 people who have side effects when taking Tenormin from the FDA, and is updated regularly.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,474 Tenormin users. Check the latest studies of Tenormin.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 928 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

On Jul, 11, 2026

20,083 people reported to have side effects when taking Tenormin.
Among them, 35 people (0.17%) have Urination - excessive volume.

Could Tenormin cause Urination - excessive volume?

Among these 35 people:

How long have people been on Tenormin when they have Urination - excessive volume? *

What is the gender of people who have Urination - excessive volume when taking Tenormin? *

female: 25.71 %
male: 74.29 %

What is the age of people who have Urination - excessive volume when taking Tenormin? *

What are other drugs people take besides Tenormin? *

What are other side effects people have besides Urination - excessive volume? *

Dyspnea (difficult or laboured breathing): 16 people, 45.71%
Blood Creatinine Increased: 16 people, 45.71%
Blood Urea Increased: 15 people, 42.86%
Pleural Effusion (water on the lungs): 15 people, 42.86%
Weakness: 14 people, 40.00%
Constipation: 14 people, 40.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 14 people, 40.00%
Hyperglycemia (high blood sugar): 13 people, 37.14%
Multiple Myeloma (cancer of the plasma cells): 12 people, 34.29%
Hyperhidrosis (abnormally increased sweating): 12 people, 34.29%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 31.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 11.43%
Depression: 3 people, 8.57%
High Blood Cholesterol: 2 people, 5.71%
Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 5.71%
Supraventricular Extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle): 2 people, 5.71%
Parkinson's Disease: 2 people, 5.71%
Memory Loss: 2 people, 5.71%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 5.71%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Tenormin and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tenormin:

Tenormin (20,474 reports)

Browse all side effects of Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (928 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Tenormin) and Tenormin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.